Literature DB >> 32318680

Sore throat as a side effect of abobotulinum toxin A injection for upper limb spasticity after stroke: A case report.

Esra Giray1, Evrim Karadag-Saygı1.   

Abstract

Despite sore throat exists in the product characteristics of abobotulinum toxin A as one of the side effects, no available reports of sore throat after abobotulinum toxin A injection for adult upper limb spasticity could be found in the literature to guide physicians for the management. Herein, we report a case of poststroke spasticity who develop sore throat immediately after abobotulinum toxin A (Dysport®) injection of forearm muscles which completely resolved after observation for eight hours. This case report highlights a rare side effect of abobotulinum toxin A and provides information regarding the follow-up process of side effects which would guide physicians for the management.
Copyright © 2020, Turkish Society of Physical Medicine and Rehabilitation.

Entities:  

Keywords:  Adverse drug event; botulinum toxins type A; sore throat; spasticity

Year:  2020        PMID: 32318680      PMCID: PMC7171893          DOI: 10.5606/tftrd.2020.4562

Source DB:  PubMed          Journal:  Turk J Phys Med Rehabil        ISSN: 2587-1250


  5 in total

1.  Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.

Authors:  Jean-Michel Gracies; Allison Brashear; Robert Jech; Peter McAllister; Marta Banach; Peter Valkovic; Heather Walker; Christina Marciniak; Thierry Deltombe; Alexander Skoromets; Svetlana Khatkova; Steven Edgley; Fatma Gul; France Catus; Beatrice Bois De Fer; Claire Vilain; Philippe Picaut
Journal:  Lancet Neurol       Date:  2015-08-26       Impact factor: 44.182

2.  Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia.

Authors:  C L Comella; J Jankovic; K M Shannon; J Tsui; M Swenson; S Leurgans; W Fan
Journal:  Neurology       Date:  2005-11-08       Impact factor: 9.910

3.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

Review 4.  Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature.

Authors:  Beth E Crowner; Diego Torres-Russotto; Alexandre R Carter; Brad A Racette
Journal:  Clin Neuropharmacol       Date:  2010 Sep-Oct       Impact factor: 1.592

5.  Does botulinum toxin alter laryngeal secretions and mucociliary transport?

Authors:  K V Fisher; C L Giddens; S D Gray
Journal:  J Voice       Date:  1998-09       Impact factor: 2.009

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.